Greenwich, Connecticut-based private investment firm Great Point Partners recently expanded its Europe-based operations with a new office in London to leverage its ability to reach health care companies on a transatlantic scale.
“Our London office will enable us to strengthen our partnerships with entrepreneurs to build global health care businesses,” Dr. Jeffrey Jay, founder and managing partner of GPP, told Businesswire. “This expansion is a testament to our success in helping United States-based companies expand into European markets and vice versa.”
The new establishment is one of Great Point Partners’ efforts to merge its North American and European networks to leverage its existing slate of companies and promote global growth.
“GPP aims to leverage its deep health care industry expertise and network of entrepreneurs, operating partners and industry experts across Europe to remove barriers to entry for middle-market health care companies seeking European expansion,” Businesswire said.
Managing Director and Head of Private Equity Noah Rhodes has been appointed to oversee the development of the new venture.
The London-based team will work in close collaboration with GPP’s U.S.-based team to seek “greater access to the firm’s operational knowledge base for navigating markets across the U.K. and E.U.”
The company has appointed two London-based executives, Senior Vice President David Slattery and Isaac Kang, associate to lead the European firm. GPP’s European investing activities will continue to be led by an integrated team based out of both Greenwich and London.
“We believe that having an on-the-ground presence in Europe will benefit both our existing and prospective partners in accelerating their growth and expanding internationally, and also conveys our commitment to the European market,” Rhodes told Businesswire.
GPP is credited with helping various companies reach transatlantic scale, including Belgium-based cell and gene therapy contract development and manufacturing organization, MaSTherCell; U.K.-based provider of passive temperature-controlled packaging solutions aimed at the pharmaceutical, life science and cold chain logistics industries, Softbox; and U.S.-based provider of evidence solutions and data CorEvitas, as well as MLM Medical Labs, a specialty central lab based in Germany; SteriPack, based in Ireland; and Clinical Supplies Management, a U.S.-based pharmaceutical and services company.